Business Context and Reporting Period
Company: Gyrodyne, LLC (GYRO)
Filing Type: Form 8-K (Current Report)
Date of Report: July 30, 2025 (Event Date); August 4, 2025 (Signature Date)
Context: The Company, a New York limited liability company, is in the process of liquidating its assets. This filing announces the execution of a Material Definitive Agreement for the sale of a significant portion of its remaining real estate holdings.
Key Financial Metrics and Transaction Details
- Transaction: Sale of an approximately 49-acre vacant land parcel (part of the Flowerfield complex in St. James, NY) to B2K Smithtown LLC.
- Purchase Price Range: $24,000,000 to $28,740,000, contingent on the number of market-rate units approved for the buyer.
- Earnest Money Deposit: $250,000.
- Estimated Net Asset Value (NAV): Approximately $32.6 million total.
- Estimated NAV Per Share: Approximately $14.83 (as of June 30, 2025).
- Liquidity/Cash Flow: The filing does not provide specific current cash flow or liquidity figures, noting that the NAV estimate includes additional estimated costs associated with extending the liquidation timeline.
Material Changes and Timeline Adjustments
The execution of this agreement results in a material change to the Company's liquidation schedule:
- Revised Liquidation Timeline: The Company is extending its estimated timeline to complete liquidation to December 31, 2027.
- Closing Date Estimates:
- Standard: No later than December 2027 (8 months after Site Plan Approval).
- With Extensions: By August 2028 if the buyer exercises both site plan extension options.
- Contingencies: The deal is subject to a 90-day investigation period and the buyer obtaining Subdivision Approval and other required approvals within 18 months. Failure to obtain approvals allows the buyer to terminate or waive contingencies to close.
Outlook, Risks, and Management Commentary
Management Commentary: The NAV estimates are based on the assumption that Site Plan Approval is received for the number of units sought under the agreement. The estimates account for costs incurred by extending the liquidation timeline.
Risks and Contingencies:
- Approval Risk: The transaction is contingent on regulatory approvals (Subdivision and Site Plan) which the buyer must obtain at their own expense.
- Termination Risk: The buyer may terminate the agreement during the 90-day investigation period if not satisfied with title or premises suitability.
- Legal and Operational Risks: Ongoing Article 78 proceeding against the Company, potential litigation, community activism, and proxy contests.
- Market Risks: Real estate market conditions in Suffolk and Westchester Counties, inflation, elevated interest rates, and banking sector instability.
Investor Verification Checklist
- Verify the final approved number of market-rate units, as this directly determines the purchase price within the $24M–$28.74M range.
- Monitor the status of the 90-day investigation period and the subsequent 18-month approval period for potential termination.
- Review the full text of the Purchase and Sale Agreement (Exhibit 10.1) for specific covenants and extension rights.
- Track the progress of the Article 78 proceeding and any related litigation that could impact asset value or sale timing.
- Confirm the updated liquidation timeline and associated carrying costs as the Company moves toward the December 2027 target.